United States Prenatal Diagnostic Market Estimated to Reach USD 1429.5 Mn by 2022 - Growing Research Activities on Human Genomics to Boost Growth
The author of the report analyzed that the United States Prenatal Diagnostic Market accounted for US$ 527.5 million in 2017. The current focus in prenatal genetic testing and evaluation is on the identification of pathological conditions associated with clinically defined diseases caused by sequence variation in genomic DNA. Prenatal diagnostic procedures have been developed to detect birth defects in utero.
View full press release